Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.

Sheikh I, Fontenot E, Waghray N, Ismail MK, Tombazzi C, Smith JL.

JOP. 2014 May 27;15(3):219-24. doi: 10.6092/1590-8577/2258. Review.

2.

Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?

Cheon YK.

Korean J Intern Med. 2013 Mar;28(2):141-8. doi: 10.3904/kjim.2013.28.2.141. Epub 2013 Feb 27. Review.

3.

NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: ready for prime time?

Parsi MA.

World J Gastroenterol. 2012 Aug 14;18(30):3936-7. doi: 10.3748/wjg.v18.i30.3936.

4.

Prophylaxis of post-ERCP pancreatitis: a practice survey.

Dumonceau JM, Rigaux J, Kahaleh M, Gomez CM, Vandermeeren A, Devière J.

Gastrointest Endosc. 2010 May;71(6):934-9, 939.e1-2. doi: 10.1016/j.gie.2009.10.055. Epub 2010 Mar 11.

PMID:
20226455
5.

European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.

Dumonceau JM, Andriulli A, Deviere J, Mariani A, Rigaux J, Baron TH, Testoni PA; European Society of Gastrointestinal Endoscopy.

Endoscopy. 2010 Jun;42(6):503-15. doi: 10.1055/s-0029-1244208. Epub 2010 May 26.

6.

A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.

Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD.

Gut. 2008 Sep;57(9):1262-7. doi: 10.1136/gut.2007.140756. Epub 2008 Mar 28. Review.

PMID:
18375470
7.

Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis.

Ding X, Chen M, Huang S, Zhang S, Zou X.

Gastrointest Endosc. 2012 Dec;76(6):1152-9. doi: 10.1016/j.gie.2012.08.021.

PMID:
23164513
8.

A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Sethi S, Sethi N, Wadhwa V, Garud S, Brown A.

Pancreas. 2014 Mar;43(2):190-7. doi: 10.1097/MPA.0000000000000090. Review.

PMID:
24518496
9.

Post-ERCP pancreatitis: review of current preventive strategies.

Feurer ME, Adler DG.

Curr Opin Gastroenterol. 2012 May;28(3):280-6. doi: 10.1097/MOG.0b013e3283528e68. Review.

PMID:
22450899
10.

Selective biliary cannulation techniques for endoscopic retrograde cholangiopancreatography procedures and prevention of post- endoscopic retrograde cholangiopancreatography pancreatitis.

Mukai S, Itoi T.

Expert Rev Gastroenterol Hepatol. 2016 Jun;10(6):709-22. doi: 10.1586/17474124.2016.1143774. Epub 2016 Feb 6. Review.

PMID:
26782710
11.

Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.

Wagh MS, Sherman S.

Am J Gastroenterol. 2007 May;102(5):984-6.

PMID:
17489783
12.

Post-ERCP pancreatitis and its prevention.

Frank CD, Adler DG.

Nat Clin Pract Gastroenterol Hepatol. 2006 Dec;3(12):680-8. Review.

PMID:
17130878
13.

Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet?

Yang D, Draganov PV.

World J Gastroenterol. 2012 Aug 21;18(31):4082-5. doi: 10.3748/wjg.v18.i31.4082.

14.

Preventing pancreatitis after endoscopic retrograde cholangiopancreatography.

Kubiliun NM, Elmunzer BJ.

Gastrointest Endosc Clin N Am. 2013 Oct;23(4):769-86. doi: 10.1016/j.giec.2013.06.003. Epub 2013 Jul 11. Review.

PMID:
24079789
15.

Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.

Li X, Tao LP, Wang CH.

World J Gastroenterol. 2014 Sep 14;20(34):12322-9. doi: 10.3748/wjg.v20.i34.12322. Review.

16.

Complications of ERCP.

Talukdar R.

Best Pract Res Clin Gastroenterol. 2016 Oct;30(5):793-805. doi: 10.1016/j.bpg.2016.10.007. Epub 2016 Oct 27. Review.

PMID:
27931637
17.

Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis.

Rustagi T, Jamidar PA.

Gastrointest Endosc Clin N Am. 2015 Jan;25(1):107-21. doi: 10.1016/j.giec.2014.09.006. Review.

PMID:
25442962
19.

Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.

Choi CW, Kang DH, Kim GH, Eum JS, Lee SM, Song GA, Kim DU, Kim ID, Cho M.

Gastrointest Endosc. 2009 Apr;69(4):e11-8. doi: 10.1016/j.gie.2008.10.046.

PMID:
19327467
20.

The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.

Ahmad D, Lopez KT, Esmadi MA, Oroszi G, Matteson-Kome ML, Choudhary A, Bechtold ML.

Pancreas. 2014 Apr;43(3):338-42. doi: 10.1097/MPA.0000000000000086.

PMID:
24622061

Supplemental Content

Support Center